Skip to main content

Animations

MJFF Publications

4811 - 4820 of 8404 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-020-09856-7
    Best OA location URL:
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2019-321759
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0, cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0230815
    Citation Count: 33
  • Summary Details
    RESTRICTED
    Title: Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson’s Disease
    Journal Name: Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40265-020-01310-2
    Citation Count: 28
  • Summary Details
    OPEN
    Title: CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-020-00192-4
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00370
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Revised Self-Monitoring Scale
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000009451
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity
    Journal Name: Toxins
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/toxins12050292
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?
    Journal Name: Expert Opinion on Therapeutic Targets
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14728222.2020.1758668
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14737175.2020.1752669
    Best OA location URL:
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.